MIRA PHARMACEUTICALS, INC.

MIRA

MIRA PHARMACEUTICALS, INC.

MIRA

Insider Sentiment (TTM):

Last Purchase:2024-05-21Last Sale:2025-10-16Shares Purchased (TTM):0Shares Sold (TTM):613,595

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,146,749Shares Outstanding:41,941,370Institutional Ownership Pct.:5.12%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	4	5	6	3	1	1	3	4	3	4	5	6
Assets Current
Assets Current	8	9	11	8	1	1	3	4	3	4	5	6
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	-	0	-
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Investments	5	5	5	5	-	-	-	-	-	-	-	-
Deferred Finance Costs Net	-	-	-	-	-	-	-	-	-	-	-	3
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	0	0	-
Other Receivables	-	-	-	-	-	-	-	-	-	-	0	-
Assets	8	9	11	8	1	1	3	4	3	4	5	9
Liabilities And Stockhold…
Accounts Payable Current	0	0	0	0	0	0	1	1	1	1	1	1
Liabilities Current
Accrued Liabilities Current	-	-	-	-	-	0	-	-	-	-	-	-
Liabilities Current	0	0	1	0	0	0	1	1	1	1	1	1
Other Liabilities Current	-	-	1	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Liabilities	0	0	1	0	0	0	1	1	1	1	1	1
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	50	50	50	41	33	32	31	30	27	26	26	24
Stockholders Equity	8	9	10	8	1	1	2	4	2	3	4	8
Retained Earnings Accumulated Deficit	-42	-41	-40	-34	-32	-31	-29	-27	-25	-23	-21	-15
Preferred Stock Par Or Stated Value Per Share	-	0	0	0	0	0	0	0	0	0	0	0
Liabilities And Stockholders Equity	8	9	11	8	1	1	3	4	3	4	5	9
Preferred Stock No Par Value	-	0	-	-	-	-	-	-	-	-	-	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Par Or Stated Value Per Share	-	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock No Par Value	-	0	-	-	-	-	-	-	-	-	-	-
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	42	42	42	40	17	17	17	16	15	15	15	15
Shares Outstanding	42	42	42	40	17	17	17	16	15	15	15	15

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.56%	-3.08%	-16.31%	-	-	-	-	-	-	-	-	-
2025	5.26%	-9.77%	15.79%	-4.76%	-8.16%	13.61%	8.96%	11.19%	-7.46%	-1.87%	-7.29%	-11.03%
2024	6.00%	-18.41%	202.65%	-24.39%	-43.90%	-7.32%	-25.62%	-21.25%	-25.00%	-11.42%	36.79%	14.15%
2023	-	-	-	50.16%	-52.37%	19.87%	3.20%	-26.19%	-39.26%	-20.37%	-18.06%	-33.61%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	200.08	82.16	15.75	90.53	2.79	12.86	3.99	6.11	3.68	5.70	8.70	6.99
Quick Ratio	198.75	81.97	15.71	89.79	2.45	11.36	3.92	5.98	3.54	5.41	8.27	6.76
Working Capital	8.13M	9.31M	10.36M	7.51M	534.42K	1.26M	2.16M	3.54M	2.14M	3.06M	4.30M	5.20M
Leverage & Debt
Debt to Equity	0.01	0.01	0.07	0.01	0.52	0.08	0.33	0.19	0.36	0.21	0.13	0.11
Interest Coverage TTM	-209.43	-257.26	-324.08	-338.49	-72.49	-56.94	-46.40	-5.31	-5.29	-4.88	-	-
Debt Ratio	0.00	0.01	0.06	0.01	0.34	0.08	0.25	0.16	0.26	0.17	0.11	0.10
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.01	0.01	0.00	-	-
Per Share Metrics
Diluted EPS TTM	-	-	-	-1.47	-0.46	-0.48	-0.51	-0.83	-0.96	-0.93	-	-
Free Cash Flow Per Share TTM	-0.12	-0.10	-0.20	-0.19	-0.26	-0.37	-0.36	-0.32	-0.32	-0.38	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Margin Metrics
Operating Profit Margin TTM	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-
Net Profit Margin TTM	-	-369,225.18%	-376,684.00%	-334,498.89%	-91,407.35%	-20,099.67%	-19,932.12%	-31,934.88%	-35,853.83%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-78.44%	-78.44%	-78.44%	-78.44%	-	-	-	-	-	-	-
Net Income Growth (1Y)	299.69%	296.10%	307.50%	125.85%	-45.03%	-42.20%	-	-	-	-	-	-
EPS Growth (1Y)	61.57%	57.20%	165.61%	76.61%	-52.17%	-48.67%	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-1.28	-1.43	-1.12	-0.92	-2.65	-2.06	-2.24	-1.56	-0.67	-1.19	-	-
P/B TTM	4.88	4.80	3.44	3.47	36.07	12.60	8.00	5.48	4.24	5.15	3.34	7.82
P/S TTM	-	5,282.79	4,211.71	3,085.81	2,419.50	414.05	446.90	497.33	238.99	-	-	-
Market Cap	39.79M	44.88M	35.78M	26.21M	20.55M	16.31M	17.61M	19.59M	9.42M	16.26M	14.62M	63.42M
Enterprise Value	36.19M	40.06M	29.43M	23.57M	19.82M	15.11M	14.77M	15.45M	6.59M	12.73M	10.02M	57.55M
Calculated Values
Free Cash Flow TTM	-5.07M	-4.23M	-4.66M	-3.70M	-4.45M	-6.14M	-5.56M	-4.79M	-4.71M	-5.58M	-	-
Net Debt	-3.61M	-4.82M	-6.35M	-2.64M	-730.48K	-1.21M	-2.83M	-4.14M	-2.82M	-3.53M	-4.60M	-5.87M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-10-16Sale

Owner: Aminov, Erez

Title: CEO and Chairman

Shares: 613,595

Price/Share: $2.11

Value: $1,294,685.45

Shares Owned: 3,592,666

Relationship: Director,Officer

Ownership: Direct

2024-11-20Sale

Owner: Aminov, Erez

Title: Chief Executive Officer

Shares: 44,590

Price/Share: $1.27

Value: $56,629.30

Shares Owned: 1,061,200

Relationship: Director,Officer

Ownership: Direct

2024-08-28Sale

Owner: Mcnulty, Brian Patrick, B…

Title: -

Shares: 200,000

Price/Share: $1.96

Value: $392,000.00

Shares Owned: 2,540,270

Relationship: TenPercentOwner

Ownership: Indirect

2024-05-21Purchase

Owner: Aminov, Erez

Title: Chief Executive Officer

Shares: 8,700

Price/Share: $0.95

Value: $8,265.00

Shares Owned: 382,200

Relationship: Director,Officer

Ownership: Direct

2023-12-11Sale

Owner: Mcnulty, Brian Patrick, B…

Title: -

Shares: 46,005

Price/Share: $1.55

Value: $71,307.75

Shares Owned: 660,000

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-10-16	Aminov, Erez	Director,Officer	CEO and Chairman	Direct	Sale	613,595	2.11	$1,294,685.45	3,592,666	5
2024-11-20	Aminov, Erez	Director,Officer	Chief Executive Officer	Direct	Sale	44,590	1.27	$56,629.30	1,061,200	4
2024-08-28	Mcnulty, Brian Patrick, B…	TenPercentOwner	-	Indirect	Sale	200,000	1.96	$392,000.00	2,540,270	4
2024-05-21	Aminov, Erez	Director,Officer	Chief Executive Officer	Direct	Purchase	8,700	0.95	$8,265.00	382,200	4
2023-12-11	Mcnulty, Brian Patrick, B…	TenPercentOwner	-	Indirect	Sale	46,005	1.55	$71,307.75	660,000	4
2023-08-07	Bay, Shore Trust, Cappy G…	TenPercentOwner	-	Indirect	Purchase	119,048	7.00	$833,336.00	2,859,318	4
2023-08-02	Bay, Shore Trust, Cappy G…	TenPercentOwner	-	Indirect	Purchase	157,170	7.00	$1,100,190.00	2,740,270	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

5.12%

Inst. Shares: 2,146,749

Shares Outstanding: 41,941,370

2025-12-31

9.35%

Inst. Shares: 2,216,457

Shares Outstanding: 23,694,333

2025-09-30

7.02%

Inst. Shares: 1,352,819

Shares Outstanding: 19,274,947

2025-06-30

5.71%

Inst. Shares: 970,440

Shares Outstanding: 16,986,488

2025-03-31

5.67%

Inst. Shares: 942,951

Shares Outstanding: 16,645,119

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,146,749	41,941,370	5.12%
2025-12-31	2,216,457	23,694,333	9.35%
2025-09-30	1,352,819	19,274,947	7.02%
2025-06-30	970,440	16,986,488	5.71%
2025-03-31	942,951	16,645,119	5.67%
2024-12-31	1,041,549	15,444,149	6.74%
2024-09-30	820,240	15,071,915	5.44%
2024-06-30	701,691	14,780,885	4.75%
2024-03-31	517,109	14,780,885	3.50%
2023-12-31	71,968	13,924,619	0.52%
2023-09-30	800	13,639,197	0.01%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MIRA PHARMACEUTICALS, INC. (MIRA) — SEC Financial Statements & Analysis

MIRA PHARMACEUTICALS, INC. (MIRA) is a pharmaceutical preparations company, incorporated in FL. MIRA PHARMACEUTICALS, INC. trades on Nasdaq as: MIRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MIRA PHARMACEUTICALS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.01x, a Price-to-Sales (P/S) ratio of 5282.79x (TTM), a Price-to-Book (P/B) ratio of 4.88x (TTM), at a market cap of $39.79M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.01x
P/S TTM: 5282.79x
P/B TTM: 4.88x
Market Cap: $39.79M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MIRA PHARMACEUTICALS, INC. in?

MIRA PHARMACEUTICALS, INC. (MIRA) operates in the Pharmaceutical Preparations industry.

What is MIRA's market cap?

MIRA PHARMACEUTICALS, INC. (MIRA) has a market capitalization of $39.79M as of 2026-06-30.

What exchange does MIRA trade on?

MIRA PHARMACEUTICALS, INC. (MIRA) trades on the Nasdaq.

Where is MIRA PHARMACEUTICALS, INC. incorporated?

MIRA PHARMACEUTICALS, INC. is incorporated in FL.